MedPath

TUBERSOL

Tuberculin Purified Protein Derivative(Mantoux)TUBERSOL

Approved
Approval ID

a4a732e9-b8ee-4e6d-8b9a-6a9d2c36bfcd

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 25, 2024

Manufacturers
FDA

Sanofi Pasteur Inc.

DUNS: 086723285

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tuberculin Purified Protein Derivative

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49281-752
Application NumberBLA103941
Product Classification
M
Marketing Category
C73585
G
Generic Name
Tuberculin Purified Protein Derivative
Product Specifications
Route of AdministrationINTRADERMAL
Effective DateJanuary 25, 2024
FDA Product Classification

INGREDIENTS (3)

Tuberculin Purified Protein DerivativeActive
Quantity: 5 [iU] in 0.1 mL
Code: I7L8FKN87J
Classification: ACTIB
PhenolInactive
Quantity: 0.35 mg in 0.1 mL
Code: 339NCG44TV
Classification: IACT
Polysorbate 80Inactive
Quantity: 0.0125 uL in 0.1 mL
Code: 6OZP39ZG8H
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TUBERSOL - FDA Drug Approval Details